Viewing Study NCT07279766

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2026-02-02 @ 3:56 AM
Study NCT ID: NCT07279766
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-11-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19
Sponsor: Tor Biering-Sørensen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID-19 View
None Vaccination View
None Pragmatic View
None Registry View
None Respiratory tract disease View
None Respiratory View
None Cardiovascular View